Source link : https://newshealth.biz/health-news/more-evidence-for-lower-ribociclib-dose-in-advanced-breast-cancer/
(MedPage Today) — A lower dose of the CDK4/6 inhibitor ribociclib (Kisqali) managed toxicity without compromising efficacy for women with hormone receptor (HR)-positive/HER2-negative breast cancer, according to results from two studies. A phase… Source link : https://www.medpagetoday.com/hematologyoncology/breastcancer/117649 Author : Publish date : 2025-09-25 21:01:00 Copyright for syndicated content belongs to the linked Source.
The post More Evidence for Lower Ribociclib Dose in Advanced Breast Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-25 21:01:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8